Biomedical technology

3D body scanner with AI predicts metabolic syndrome risk

Mayo Clinic researchers are using artificial intelligence (AI) with an advanced 3D body-volume scanner—originally developed for the clothing industry—to help doctors predict metabolic syndrome risk and severity. The combination ...

Oncology & Cancer

Study identifies ways to reduce cancer risk among LGBTQIA+ people

Socioeconomic status, provider-patient relationships and rural living environments have been found to affect cancer screening behaviors for people LBGTQIA+ individuals, according to a recent study from Callie Kluitenberg ...

Diseases, Conditions, Syndromes

WHO calls for cholera vaccine production boost

The head of the World Health Organization on Thursday called for increased production of cholera vaccines, highlighting what he called a "critical shortage" around the globe.

page 1 from 28

Charcot–Marie–Tooth disease- (CMT), known also as Morbus Charcot-Marie-Tooth, Charcot-Marie-Tooth neuropathy, hereditary motor and sensory neuropathy (HMSN), hereditary sensorimotor neuropathy (HSMN), or peroneal muscular atrophy, is an inherited disorder of nerves (neuropathy) that takes different forms. It is predominantly characterized by loss of muscle tissue and touch sensation, in the feet, ankles and legs as it progresses over time, but also in the hands, wrists and arms in various types of the disease. Early and late onset forms occur with 'on and off' painful spasmodic muscular contractions that can be disabling when the disease activates. High arched 'Cavus Feet' are associated with the disorder. Sensory and positioning nerves in the hands and feet are often damaged, while pain nerves are left intact. Overuse of an affected hand or limb can activate symptoms ranging from numbness, to spasm, to very painful cramping. Currently incurable, this disease is one of the most common inherited neurological disorders, and was considered a type of Muscular Dystrophy for years.

Estimates of incidence vary widely from 1 in 380,000 people affected to 1 in 2,500 people affected [1]. This larger figure might equate to approximately 23,000 people in the UK and 125,000 people in the USA.

This text uses material from Wikipedia licensed under CC BY-SA